- CEO
- Nareshkumar R. Patel
- Full Time Employees
- 1,713
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Plot No. 440/4, 5 & 6 Surat GU India 394230
- IPO Date
- Sep 14, 2021
- Business
- Acutaas Chemicals Limited (ACUTAAS.NS) engages in the research, development, manufacture and sale of pharmaceutical intermediates and specialty chemicals in India and internationally. The company offers advanced pharmaceutical intermediates and active pharmaceutical ingredients for regulated and generic applications, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant and anticoagulant therapies such as Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban; specialty chemicals for agrochemicals, cosmetics and polymers; parabens and parabens formulations; salicylic acid; electrolyte additives including Vinylene Carbonate and Fluoro Vinylene Carbonate; and other fine chemicals used in cosmetics, dyes, polymers, agrochemicals, animal foods and personal care industries. It provides custom synthesis, contract development and manufacturing organization (CDMO) services through cGMP-compliant facilities equipped with R&D laboratories, serving pharmaceutical, personal care, agrochemical and polymer sectors across more than 27 countries in the Americas, Europe and Asia. Founded in 2004 and headquartered in Surat, India, with manufacturing units in Sachin, Ankleshwar and Jhagadia in Gujarat, the company operates as a globally integrated intermediates provider with approximately 1,465 employees. In recent developments, Acutaas Chemicals changed its name from Ami Organics Limited in May 2025; acquired a 55% stake in Baba Fine Chemicals in fiscal 2024 and two units from Gujarat Organics Limited in 2021; commissioned Block 2 at its Ankleshwar CDMO facility in Q3 fiscal 2025 and began supplying under a CDMO contract with Fermion from Block 3; made its Ankleshwar Unit II GMP-compliant following a virtual audit by Japan's PMDA; and plans to commission a new electrolyte additives plant at Jhagadia by H1 fiscal 2026 with 2,000 MTPA capacity each for Vinylene Carbonate and Fluoro Vinylene Carbonate, targeting EV battery manufacturers.